About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 113 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 113 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 113 trials

Active not recruitingOcrelizumab Discontinuation in Relapsing Multiple SclerosisThis study is a prospective, multi-center, randomized, double blinded, placebo-controlled study of OCR treatment-discontinuation in patients with early RMS.NCT05285891·New Haven, Connecticut and 12 others CompletedAn Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of AlemtuzumabThis open-label, rater-blinded extension study enrolled participants who had relapsing-remitting multiple sclerosis (RRMS) and who participated in one of three prior…NCT00930553·Cullman, Alabama and 175 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedReal-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)The primary objective of the study is to evaluate relapse activity, as measured by the proportion of participants relapsed at 12 months, in participants with relapsing-remitting…NCT02159573·Birmingham, Alabama and 42 others

CompletedA Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple SclerosisThis is a phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex (interferon beta-1a) controlled dose finding study to evaluate the efficacy as…NCT00676715·Phoenix, Arizona and 83 others

RecruitingEfficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.The purpose of this Phase 3b study is to assess the efficacy, safety and tolerability of remibrutinib after switching from ocrelizumab and compared to continuous ocrelizumab…NCT06846281·Scottsdale, Arizona and 128 others

CompletedTeleconference Fatigue Management for People With Multiple SclerosisApproximately 60% of individuals with multiple sclerosis (MS) describe fatigue as their most disabling symptom.NCT00591721·Chicago, Illinois

CompletedStudy of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving TecfideraThe primary objective of this study is to evaluate whether montelukast can reduce the severity of gastrointestinal (GI) events, measured by the Gastrointestinal Symptom Rating…NCT02410278·Jonesboro, Arkansas and 49 others

CompletedFatigue Management Programs for People With MSThis is a multi-site randomized clinical trial comparing 3 modes of delivering the Managing Fatigue course for reducing fatigue in individuals with multiple sclerosis (MS).NCT03550170·Chicago, Illinois and 2 others

TerminatedThis Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.The purpose of this study is to evaluate whether FTY720 is effective in delaying MS disability progression compared to placebo in patients with PPMS.NCT00731692·Newport Beach, California and 156 others

CompletedBEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New DoseThe BEYOND Follow-Up study will give patients who participated in the preceding BEYOND study the opportunity to continue treatment with the 500µg dose of interferon beta (IFNB) 1b…NCT00459667·Birmingham, Alabama and 183 others

Active not recruitingLong-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MSThe purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab…NCT03650114·Birmingham, Alabama and 294 others

Active not recruitingA Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisThis study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).NCT03523858·Laguna Hills, California and 119 others

RecruitingThe Effect of Remotely Delivered Pilates on Physical , and Psychological Outcomes in Individuals With Multiple SclerosisObjectives Objective 1: To determine the effects of a 16-week remotely delivered Pilates intervention on walking endurance, walking speed, balance, fatigue, and pain compared to a…NCT07504120·Chicago, Illinois

CompletedPhase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple SclerosisOBJECTIVES: I.NCT00017628·Chicago, Illinois and 1 other

CompletedBEYOND Pilot StudyThe purpose of this study is to valuate safety and tolerability of Betaseron.NCT00893217·Los Angeles, California and 13 others

CompletedTraditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun.NCT03500328·Birmingham, Alabama and 46 others

CompletedEfficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisThis study assessed the safety, tolerability and efficacy of two doses of oral fingolimod compared to placebo on efficacy parameters in patients with relapsing-remitting multiple…NCT00355134·Birmingham, Alabama and 111 others

CompletedTreatment Interruption of NatalizumabThis is a randomized, rater blinded trial in patients who interrupt treatment with natalizumab with or without being treated with other immunomodulatory drugs, or continue…NCT01071083·Cullman, Alabama and 32 others

RecruitingHome Based Functional Balance Intervention for Multiple SclerosisThe study involves a two-arm, Phase 1, randomized controlled clinical trial designed to establish the feasibility and effects of a Functional Balance Intervention (FBI) on…NCT07355387·Chicago, Illinois

CompletedFecal Microbiota Transplantation (FMT) in Multiple SclerosisMultiple sclerosis (MS) is a chronic immune central nervous system (CNS) disease of unknown cause.NCT03975413·Chicago, Illinois

PreviousPage 5 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia